(Q34428681)

2 August 2017

title

Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite (English)

1 reference

2 August 2017

Yoshiyuki Yokokura

1

1 reference

2 August 2017

Yosuke Isobe

2

1 reference

2 August 2017

Shinnosuke Matsueda

3

1 reference

2 August 2017

Ryo Iwamoto

4

1 reference

2 August 2017

Tomomi Goto

5

1 reference

2 August 2017

Takeshi Yoshioka

6

1 reference

2 August 2017

Daisuke Urabe

7

1 reference

2 August 2017

Masayuki Inoue

8

1 reference

2 August 2017

Hiroyuki Arai

9

1 reference

2 August 2017

Makoto Arita

10

1 reference

2 August 2017

publication date

9 July 2014

1 reference

2 August 2017

published in

Journal of Biochemistry

1 reference

2 August 2017

volume

156

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

315-321

1 reference

Omega-3 fatty acids in inflammation and autoimmune diseases

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Specialized pro-resolving lipid mediators in the inflammatory response: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Resolvin D series and protectin D1 mitigate acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Infection regulates pro-resolving mediators that lower antibiotic requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Mediator lipidomics in acute inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Inflammation and immune regulation by 12/15-lipoxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVU044

21 January 2018

Identifiers

DOI

10.1093/JB/MVU044

1 reference

2 August 2017

1 reference